Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

RYGCENTER AARHUS KIROPRAKTISK KLINIK I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   4.3% 4.2% 4.3% 6.0% 5.8% 5.3% 14.3% 14.3%   Credit score (0-100)   49 49 47 37 39 41 15 15   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   11,753 10,643 9,794 11,339 10,048 10,204 0.0 0.0   EBITDA   5,189 5,375 4,745 6,651 5,827 5,462 0.0 0.0   EBIT   5,076 5,265 4,634 6,555 5,803 5,452 0.0 0.0   Pre-tax profit (PTP)   5,067.8 5,258.6 4,624.6 6,544.6 5,794.3 5,449.5 0.0 0.0   Net earnings   5,067.8 5,258.6 4,624.6 6,544.6 5,794.3 5,449.5 0.0 0.0   Pre-tax profit without non-rec. items   5,068 5,259 4,625 6,545 5,794 5,449 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   311 248 138 42.4 18.8 9.4 0.0 0.0   Shareholders equity total   1,443 1,285 917 828 912 414 414 414   Interest-bearing liabilities   22.0 18.0 38.5 38.2 46.7 158 0.0 0.0   Balance sheet total (assets)   2,063 1,913 1,886 1,436 1,404 1,271 414 414   Net Debt   -410 -525 -820 -573 -441 -493 -414 -414     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   11,753 10,643 9,794 11,339 10,048 10,204 0.0 0.0   Gross profit growth   17.2% -9.4% -8.0% 15.8% -11.4% 1.6% -100.0% 0.0%   Employees   14 11 9 9 9 10 0 0   Employee growth %   7.7% -21.4% -18.2% 0.0% 0.0% 11.1% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,063 1,913 1,886 1,436 1,404 1,271 414 414   Balance sheet change%   1.4% -7.3% -1.4% -23.9% -2.2% -9.5% -67.5% 0.0%   Added value   5,189.3 5,375.1 4,744.7 6,650.6 5,898.8 5,461.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -195 -172 -221 -191 -47 -19 -9 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   43.2% 49.5% 47.3% 57.8% 57.8% 53.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   247.8% 264.9% 243.9% 394.6% 408.7% 407.8% 0.0% 0.0%   ROI %   374.2% 377.7% 393.8% 691.2% 636.1% 713.1% 0.0% 0.0%   ROE %   434.7% 385.5% 420.0% 750.0% 666.1% 822.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   70.0% 67.2% 48.6% 57.7% 64.9% 32.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -7.9% -9.8% -17.3% -8.6% -7.6% -9.0% 0.0% 0.0%   Gearing %   1.5% 1.4% 4.2% 4.6% 5.1% 38.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.5% 34.5% 33.5% 28.1% 22.4% 4.9% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.4 2.4 1.7 1.8 2.2 1.1 0.0 0.0   Current Ratio   2.5 2.4 1.7 1.8 2.2 1.1 0.0 0.0   Cash and cash equivalent   431.7 543.1 858.2 610.8 487.7 651.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   941.1 865.6 663.0 507.3 605.8 108.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   371 489 527 739 655 546 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   371 489 527 739 647 546 0 0   EBIT / employee   363 479 515 728 645 545 0 0   Net earnings / employee   362 478 514 727 644 545 0 0